Skip to content
Latest News
Rewalk Robotics (RWLK) Stock Price Rallied 42.3% as Retail Investors Pushed It Higher

Rewalk Robotics Ltd (NASDAQ: RWLK) stock rallied 42.3%, driven by significant buying pressure from retail investors despite not making important announcements recently. While the overall short interest in Rewalk stock is minimal at just 226,800 sh

Simon Mugo
Inotiv (NOTV) Stock Jumps On Envigo Takeover Deal

Inotiv Inc (NASDAQ: NOTV) shares are rallying on Tuesday after the joint announcement with Envigo RMS Holding Corp that the companies have entered into an agreement for Inotiv to purchase Envigo, a provider of resea

Sam Boughedda
NanoViricides (NNVC) Stock Rallied 49.9% on Positive Results for Its COVID-19 Drug

NanoViricides Inc (NYSEAMERICAN: NNVC) stock rallied 49.9% after results of an animal trial showed that its COVID-19 drug candidate showed promise when encapsulated with Gilead’s remdesivir. The company has two drug candidates; the first is known

Simon Mugo
Sareum Shares Are Down 33.2% From Their August Highs. Will the Rally Resume?

Shares of Sareum Holdings Plc (LON: SAR) are down 33.2% from their August highs after the stock sold off significantly in recent weeks as the bullish momentum waned. The stock’s rally was fueled by investor expectations of one of the biotech firm’

Simon Mugo
SmileDirectClub (SDC) Shares Downgraded On Growth Uncertainty

SmileDirectClub (NASDAQ: SDC) shares are down over 3.8% on Tuesday, trading at $6.24. The news follows Monday's announcement that the company plans to launch in France at

Sam Boughedda
Helbiz (HLBZ) Stock Soared 152.16% on Amazon Prime Serie B Streaming Partnership

Helbiz Inc (NASDAQ: HLBZ) stock soared 152.16% after its media division signed a lucrative partnership deal with Amazon to stream all Helbiz Live content on devices and TVs equipped with Amazon Prime Video throughout Italy. The deal will also see

Simon Mugo
Luckin Coffee Enters Term Sheet To Settle U.S. Securities Class Action

Beijing-based Luckin Coffee (OTC: LKNCY), which is currently in provisional liquidation, announced Tuesday that it has entered into a binding term sheet with the plaintiffs to settle the U.S. Securities Class Action

Sam Boughedda
Viridian Therapeutics (VRDN) Stock Climbs After Pricing Public Offering

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company, has seen its shares rally premarket after announcing the pricing of its underwritten public offering. Viridian is selling approximately 6.2 million shares at a public offerin

Sam Boughedda
Pendragon (PDG) Shares Are Up 51.5% YTD on Surging Car Sales. Are There Further Gains?

Shares of Pendragon PLC (LON: PDG) are up 51.51% since January this year as investors reacted positively to measures implemented by the company’s board to turn around its business. The car dealership group reported a £35.1 million profit in the fi

Simon Mugo
National Express (NEX) Shares Rallied 9.14% on Plans To Acquire UK Rival Stagecoach

Shares of National Express Group PLC (LON: NEX) rallied 9.14% on plans to buy its main UK rival Stagecoach in an all-share transaction that would value the UK bus operator at £445 million ($609 million). The tie-up in the UK transport sector is lo

Simon Mugo
Alphawave IP (AWE) Shares Surge After 140% Revenue Growth

Shares of Alphawave IP (LON: AWE) are rallying after the company reported its interim results for the six months ended June 30.  The wired connectivity solutions firm rep

Sam Boughedda
Union Jack Oil (UJO) Shares Gain On “Highly Encouraging” Update

Union Jack Oil (LON: UJO) on Tuesday revealed a "highly encouraging" update in respect of ongoing operations at the Wressle hydrocarbon development.  The Wressle hydrocar

Sam Boughedda
United Oil & Gas (UOG) Shares Rise After Encountering Primary Reservoir Targets 

On Tuesday, United Oil & Gas (LON: UOG) said that its ASX-1X exploration well encountered at least 10m net pay in several oil-bearing reservoirs, resulting in its share price rising.

Sam Boughedda
Botswana Diamonds (BOD) Shares Jump After 9 Hole Drilling Programme Complete

Shares of Botswana Diamonds (LON: BOD) are gaining on Tuesday morning after the company completed the nine-hole drilling programme on the Thorny River property in South Africa.

Sam Boughedda
Innate Pharma (IPHA) Stock Soars on Positive Results From AstraZeneca’s Joint Study

Innate Pharma SA (NASDAQ: IPHA) stock soared 108% higher after AstraZeneca announced a joint clinical study’s positive phase 2 clinical trial data. AstraZeneca revealed that the study, which combined Innate Pharma’s monalizumab and AZN’s durvaluma

Simon Mugo
Caerus Mineral (CMRS) Shares Edged 4.35% Higher on Copper and Gold Discoveries

Shares of Caerus Mineral Resources PLC (LON: CMRS) on positive updates regarding its dump evaluation program of its Kalavasos Project in Cyprus. The mining and mineral exploration company revealed that initial assay results had shown significant c

Simon Mugo
Myhealthchecked (MHC) Shares Rallied 16.7% on Reaction to New UK Govt Travel Rules

Myhealthchecked PLC (LON: MHC) shares rallied 16.74% after re-issuing a statement regarding the British government’s revised testing regimes for travellers arriving in the country from specific countries. The British government is set to lift the

Simon Mugo
Haydale Graphene (HAYD) Shares Just Crashed 18.8% to Key Support. Should You Buy?

Shares of Haydale Graphene Industries PLC (LON: HAYD) crashed 18.8% after announcing a discounted share placement to raise £4.5 million via an accelerated bookbuild. Investors were not happy to see that the shares sold during the placement were pr

Simon Mugo
Globalstar (GSAT) Stock Is Down 31.9% Over the Past Week. Will It Keep Falling?

Globalstar, Inc. (NYSEAMERICAN: GSAT) stock price is down 31.9% over the past week ever since Apple Inc announced that the iPhone 13 would not support satellite communication as many reviewers and investors were expecting. Most of the company’s sh

Simon Mugo
Edesa Biotech (EDSA) Stock Was Up 70% After Its COVID-19 Drug Reduced the Patient Mortality Rate

Edesa Biotech Inc (NASDAQ: EDSA) stock was up 70% premarket after releasing excellent results from its phase 2 clinical trial of its monoclonal antibody candidate EB05 as a single-dose treatment for hospitalized COVID-19 patients. The study was pr

Simon Mugo
Analysis Stocks Markets Strategies